Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation

NCT00985985 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

723

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking

Interventions

DRUG: Nicotine
DRUG: Placebo

Sponsor

GlaxoSmithKline